Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Erectile Dysfunction Market Rebounding After Vision Scare

This article was originally published in The Pink Sheet Daily

Executive Summary

Playing field is leveled for Cialis, Levitra and the veteran Viagra after contraction in the U.S. market, Icos says.

You may also be interested in...



Lilly Acquires ICOS To Bring Full Value Of Cialis In House

$2.1 bil. deal will allow Lilly to benefit from efficiencies in development, marketing and sales of the erectile dysfunction product.

Lilly Acquires ICOS To Bring Full Value Of Cialis In House

$2.1 bil. deal will allow Lilly to benefit from efficiencies in development, marketing and sales of the erectile dysfunction product.

Cialis Once-A-Day Could Launch In Late 2007, ICOS Says

Lilly ICOS’ tadalafil once-daily 5 mg strength is submitted in the EU, with U.S. filing expected to follow by year-end.

Topics

UsernamePublicRestriction

Register

MT142639

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel